| 2026-03-25 |
复牌提示：
2026-03-24 19:50:00 停牌，复牌日期 2026-03-25 09:00:00
|
| 2026-03-20 |
详情>>
股本变动：
变动后总股本236.56万股
|
| 2026-03-20 |
详情>>
拆分方案：
每4.0000合并分成1.0000股
|
| 2025-12-30 |
详情>>
业绩披露：
2025年中报每股收益-0.01美元,归母净利润-550万美元,同比去年增长-2411.42%
|
| 2025-06-13 |
股东大会：
将于2025-07-21召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2024;
2.To re-appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2025, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year;
3.To re-elect Messrs. Alexander Rabinovitch, Shlomo Shalev, and Doron Turgeman to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex A hereto;
4.To approve the engagement terms of Mr. Noam Band in his capacity as our Chief Executive Officer;
5.To approve the grant of 10,000,000 options to Mr. Shlomo Shalev, our Chairman of the Board;
6.To approve, including for the purpose of Nasdaq Rule §5635(c), a private placement of up to US$1.0 Million in the form of convertible unsecured subordinated debentures pursuant to Rule 506(b) of Regulation D under the Securities Act of 1933, as amended from certain investors, including Interested Parties.
|
| 2025-06-13 |
股东大会：
将于2025-07-21召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2024;
2.To re-appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2025, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year;
3.To re-elect Messrs. Alexander Rabinovitch, Shlomo Shalev, and Doron Turgeman to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex A hereto;
4.To approve the engagement terms of Mr. Noam Band in his capacity as our Chief Executive Officer;
5.To approve the grant of 10,000,000 options to Mr. Shlomo Shalev, our Chairman of the Board;
6.To approve, including for the purpose of Nasdaq Rule §5635(c), a private placement of up to US$1.0 Million in the form of convertible unsecured subordinated debentures pursuant to Rule 506(b) of Regulation D under the Securities Act of 1933, as amended from certain investors, including Interested Parties.
|
| 2024-12-30 |
详情>>
业绩披露：
2024年中报每股收益0.00美元,归母净利润-21.9万美元,同比去年增长82.93%
|
| 2024-06-12 |
股东大会：
将于2024-07-22召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2023.
2.To re-appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2024, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year.
3.To re-elect Messrs. Alexander Rabinovitch, Shlomo Shalev, and Doron Turgeman to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex A hereto.
4.To approve the terms and provisions of the acquisition of The Social Proxy Ltd. (“Social Proxy”), as further detailed in the Company’s Form 6-K dated June 5, 2024 (the “Transaction”) which includes (a) the issuance to the shareholders of Social Proxy such number of ADS’s of the Company which represent 44.6% of the issued and outstanding share capital of the Company and (b) the payment of US$430,000 in cash to the shareholders of Social Proxy.
5.To approve that the Company shall enter into any and all agreement and other documents required in order to effect the Transaction and to authorize, empower and direct the Chief Executive Officer of the Company, in the name and on behalf of the Company, to take or cause to be taken any and all such further actions and to prepare, execute, deliver and file, or cause to be prepared, executed, delivered and filed any documents and such other reports, schedules, statements, consents, documents, agreements, certificates, undertakings in the name of and on behalf of the Company as he shall in his judgment, with the advice of counsel, determine to be necessary, proper or desirable to carry out fully the intent and purposes of the foregoing resolutions in order to consummate the transactions contemplated by the foregoing resolutions (the “Consummation”).
6.To approve, conditional upon the Consummation of the Transaction, the election of Mr. Tal Klinger and Mr. Yair Redl to our Board of Directors each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex B hereto.
|
| 2024-06-12 |
股东大会：
将于2024-07-22召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2023.
2.To re-appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2024, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year.
3.To re-elect Messrs. Alexander Rabinovitch, Shlomo Shalev, and Doron Turgeman to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex A hereto.
4.To approve the terms and provisions of the acquisition of The Social Proxy Ltd. (“Social Proxy”), as further detailed in the Company’s Form 6-K dated June 5, 2024 (the “Transaction”) which includes (a) the issuance to the shareholders of Social Proxy such number of ADS’s of the Company which represent 44.6% of the issued and outstanding share capital of the Company and (b) the payment of US$430,000 in cash to the shareholders of Social Proxy.
5.To approve that the Company shall enter into any and all agreement and other documents required in order to effect the Transaction and to authorize, empower and direct the Chief Executive Officer of the Company, in the name and on behalf of the Company, to take or cause to be taken any and all such further actions and to prepare, execute, deliver and file, or cause to be prepared, executed, delivered and filed any documents and such other reports, schedules, statements, consents, documents, agreements, certificates, undertakings in the name of and on behalf of the Company as he shall in his judgment, with the advice of counsel, determine to be necessary, proper or desirable to carry out fully the intent and purposes of the foregoing resolutions in order to consummate the transactions contemplated by the foregoing resolutions (the “Consummation”).
6.To approve, conditional upon the Consummation of the Transaction, the election of Mr. Tal Klinger and Mr. Yair Redl to our Board of Directors each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex B hereto.
|
| 2024-05-13 |
详情>>
业绩披露：
2024年一季报每股收益0.00美元,归母净利润48.50万美元,同比去年增长152.77%
|
| 2024-04-30 |
详情>>
业绩披露：
2021年年报每股收益0.00美元,归母净利润43.50万美元,同比去年增长114.73%
|
| 2024-03-21 |
股东大会：
将于2024-04-30召开股东大会
会议内容 ▼▲
- 1.To re-elect Ms. Osnat Hillel Fein to hold office, for an additional term, as an external director of the Company, commencing as of March 25, 2024 for a period of Three (3) years, until March 24, 2027.
2.To approve the grant of 20,000 options to Mr. Doron Turgeman, our Chairman of the Board.
3.To approve the grant of 10,000 options to Ms. Osnat Hillel Fein, our External Director.
4.To approve the grant of 8,500 options to Ms. Iris Shapiro Yalon, our External Director.
5.To approve the grant of 100,000 options to Mr. Shlomo Shalev, our Chief Executive Officer.
6.To ratify an amendment to the Company’s compensation policy as proposed within the Board of Directors resolution dated as of November 23, 2023 with respect to the adoption of a new clawback policy, so that when so adopted such clawback policy will be attached as an exhibit to the Company’s Compensation Policy and form an integral part thereof, intended to comply with the clawback-related listing standards proposed by the Nasdaq Stock Market and the Israeli Companies Law 5759-1999, as amended, to take effect as of December 1, 2023.
7.To approve, including for the purpose of Nasdaq Rule §5635(c), a private placement of US$1.5 Million from certain investors, including an Interested Party, to be funded conditional upon the consummation of the acquisition of The Social Proxy Ltd., as detailed in the Company’s Form 6-K dated March 21, 2024.
|
| 2024-03-21 |
股东大会：
将于2024-04-30召开股东大会
会议内容 ▼▲
- 1.To re-elect Ms. Osnat Hillel Fein to hold office, for an additional term, as an external director of the Company, commencing as of March 25, 2024 for a period of Three (3) years, until March 24, 2027.
2.To approve the grant of 20,000 options to Mr. Doron Turgeman, our Chairman of the Board.
3.To approve the grant of 10,000 options to Ms. Osnat Hillel Fein, our External Director.
4.To approve the grant of 8,500 options to Ms. Iris Shapiro Yalon, our External Director.
5.To approve the grant of 100,000 options to Mr. Shlomo Shalev, our Chief Executive Officer.
6.To ratify an amendment to the Company’s compensation policy as proposed within the Board of Directors resolution dated as of November 23, 2023 with respect to the adoption of a new clawback policy, so that when so adopted such clawback policy will be attached as an exhibit to the Company’s Compensation Policy and form an integral part thereof, intended to comply with the clawback-related listing standards proposed by the Nasdaq Stock Market and the Israeli Companies Law 5759-1999, as amended, to take effect as of December 1, 2023.
7.To approve, including for the purpose of Nasdaq Rule §5635(c), a private placement of US$1.5 Million from certain investors, including an Interested Party, to be funded conditional upon the consummation of the acquisition of The Social Proxy Ltd., as detailed in the Company’s Form 6-K dated March 21, 2024.
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益0.00美元,归母净利润-128.3万美元,同比去年增长-680.54%
|
| 2023-05-16 |
详情>>
业绩披露：
2023年一季报每股收益0.00美元,归母净利润-91.9万美元,同比去年增长-281.62%
|
| 2023-01-20 |
股东大会：
将于2023-02-23召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2021.
2.To re-appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2022, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year.
3.To re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next Annual Meeting.
4.To re-elect Mrs. Iris Shapira Yalon to hold office as an external director of the Company for a second consecutive three (3) years term.
5.To approve the grant of 150,000 options to Mrs. Iris Shapira Yalon.
|
| 2023-01-20 |
股东大会：
将于2023-02-23召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2021.
2.To re-appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2022, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year.
3.To re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next Annual Meeting.
4.To re-elect Mrs. Iris Shapira Yalon to hold office as an external director of the Company for a second consecutive three (3) years term.
5.To approve the grant of 150,000 options to Mrs. Iris Shapira Yalon.
|
| 2022-01-19 |
股东大会：
将于2022-01-19召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2020.
2.To appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2021, instead of Kesselman & Kesselman, Certified Public Accountants, a member firm of PrincewaterhouseCoopers International Limited, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year.
3.To re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex A hereto.
|
| 2022-01-19 |
股东大会：
将于2022-01-26召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2020.
2.To appoint Somekh Chaikin, Certified Public Accountants in Israel and a member firm of KPMG as the Company’s independent auditors for the fiscal year ending December 31, 2021, instead of Kesselman & Kesselman, Certified Public Accountants, a member firm of PrincewaterhouseCoopers International Limited, and to authorize the Board of Directors, upon the recommendation of the Company’s audit committee (the “Audit Committee”), to determine the auditors’ remuneration to be fixed in accordance with the volume and nature of their services to the Company for such fiscal year.
3.To re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached as Annex A hereto.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-29 |
股东大会：
将于2021-03-29召开股东大会
会议内容 ▼▲
- 1.To re-elect Ms. Osnat Hillel Fein to hold office, for a third term, as an external director of the Company, commencing as of March 25, 2021 for a period of Three (3) years, until March 24, 2024.
|
| 2021-03-29 |
股东大会：
将于2021-04-05召开股东大会
会议内容 ▼▲
- 1.To re-elect Ms. Osnat Hillel Fein to hold office, for a third term, as an external director of the Company, commencing as of March 25, 2021 for a period of Three (3) years, until March 24, 2024.
|
| 2021-03-29 |
股东大会：
将于2021-04-05召开股东大会
会议内容 ▼▲
- 1.To re-elect Ms. Osnat Hillel Fein to hold office, for a third term, as an external director of the Company, commencing as of March 25, 2021 for a period of Three (3) years, until March 24, 2024.
|
| 2020-12-31 |
股东大会：
将于2020-12-31召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2019.
2.To approve the re-appointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2020 and until our next annual general meeting of shareholders, and to authorize our Board of Directors to fix such accounting firm’s annual compensation.
3.To re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached hereto as Annex A.
4.To approve the renewal of the approved Compensation Policy of the Company, in accordance with the requirements of the Israeli Companies Law 5759-1999 (the “Companies Law”), for a period of three years, in the form attached hereto as Annex B.
|
| 2020-12-31 |
股东大会：
将于2021-01-17召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2019. _x000D_
2.To approve the re-appointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2020 and until our next annual general meeting of shareholders, and to authorize our Board of Directors to fix such accounting firm’s annual compensation._x000D_
3.To re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached hereto as Annex A._x000D_
4.To approve the renewal of the approved Compensation Policy of the Company, in accordance with the requirements of the Israeli Companies Law 5759-1999 (the “Companies Law”), for a period of three years, in the form attached hereto as Annex B.
|
| 2020-12-31 |
股东大会：
将于2021-01-17召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended as of December 31, 2019. _x000D_
2.To approve the re-appointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2020 and until our next annual general meeting of shareholders, and to authorize our Board of Directors to fix such accounting firm’s annual compensation._x000D_
3.To re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached hereto as Annex A._x000D_
4.To approve the renewal of the approved Compensation Policy of the Company, in accordance with the requirements of the Israeli Companies Law 5759-1999 (the “Companies Law”), for a period of three years, in the form attached hereto as Annex B.
|
| 2020-05-26 |
股东大会：
将于2020-06-30召开股东大会
会议内容 ▼▲
- 1.To approve the employment terms of Mr. Shlomo Shalev in his capacity as the Chief Executive Officer (“CEO”) of the Company.
|
| 2020-01-22 |
股东大会：
将于2020-01-29召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended December 31, 2018._x000D_
2.To approve the reappointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019 and until our next annual general meeting of shareholders, and to authorize our Board of Directors to fix such accounting firm''s annual compensation._x000D_
3.To re-elect Mr. Alexander Rabinovitch to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
4.To re-elect Dr. Jonathan Schapiro to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
5.To re-elect Mr. Shlomo Shalev to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
6.To re-elect Mr. Doron Turgeman to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
7.To re-elect Dr. Dobroslav Melamed to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
8.To elect Mrs. Iris Shapira Yalon to hold office as external director of the Company Board of Directors, commencing as of the Meeting date and for a period of Three (3) years thereon._x000D_
9.To approve the appointment of Doron Turgeman as CEO including his terms of employment in such capacity commencing as of the Meeting date.
|
| 2020-01-22 |
股东大会：
将于2020-01-29召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended December 31, 2018._x000D_
2.To approve the reappointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019 and until our next annual general meeting of shareholders, and to authorize our Board of Directors to fix such accounting firm''s annual compensation._x000D_
3.To re-elect Mr. Alexander Rabinovitch to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
4.To re-elect Dr. Jonathan Schapiro to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
5.To re-elect Mr. Shlomo Shalev to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
6.To re-elect Mr. Doron Turgeman to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
7.To re-elect Dr. Dobroslav Melamed to our Board of Directors for a term expiring at our next annual general meeting of shareholders._x000D_
8.To elect Mrs. Iris Shapira Yalon to hold office as external director of the Company Board of Directors, commencing as of the Meeting date and for a period of Three (3) years thereon._x000D_
9.To approve the appointment of Doron Turgeman as CEO including his terms of employment in such capacity commencing as of the Meeting date.
|
| 2018-12-20 |
股东大会：
将于2018-12-27召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended December 31, 2017.
2.To approve the re-appointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the year ending December 31, 2018 and until our next annual general meeting of shareholders, and to authorize our board of directors to fix such accounting firm’s annual compensation.
3.To elect or re-elect Messrs. Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached hereto as Annex A.
4.To approve the employment terms of Mr. Doron Turgeman, the Chairman of the Board of the Company.
|
| 2018-05-15 |
股东大会：
将于2018-05-22召开股东大会
会议内容 ▼▲
- 1.To re-elect Mr. Oded Nagar to hold office as an external director of the Company, commencing on March 25, 2018 for a period of Three (3) years, until March 24, 2021.
2.To re-elect Mrs. Osnat Hillel Fein to hold office as an external director of the Company, commencing on March 25, 2018 for a period of Three (3) years, until March 24, 2021.
|
| 2017-07-27 |
股东大会：
将于2017-08-03召开股东大会
会议内容 ▼▲
- 1.To discuss the auditor’s report of our independent registered public accounting firm and audited financial statements for the year ended December 31, 2015 and December 31, 2016.
2.To approve the re-appointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the year ending December 31, 2017 and until our next annual general meeting of shareholders, and to authorize our board of directors to fix such accounting firm’s annual compensation.
3.To elect or re-elect Messrs Alexander Rabinovitch, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to our Board of Directors, each for a term expiring at our next annual general meeting of shareholders (a separate vote for each director will be taken). Declaration of Directors Qualification is attached hereto as Annex A.
4.To increase our authorized share capital by NIS 75,000,000, such that following the increase, the authorized share capital shall equal NIS 145,000,000 divided into 1,450,000,000 ordinary shares, par value NIS 0.1 each, and to amend our articles of association accordingly.
5.To approve the new employment terms of Mr. Joshua Levine, the Company’s Chief Executive Officer, including issuance of 1,000,000 options to purchase ordinary shares of the Company available through the Company’s ESOP.
6.To approve new Compensation Policy, in accordance with the requirements of the Israeli Companies Law 5759-1999, for a period of three years.
|
| 2017-01-24 |
详情>>
拆分方案：
每5.0000合并分成1.0000股
|
| 2016-03-24 |
股东大会：
将于2016-03-31召开股东大会
会议内容 ▼▲
- 1. To approve the appointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016 and to authorize the Board of Directors to fix such firm’s annual compensation in accordance with the volume and nature of its services.
2. To re-elect Messrs. David Bassa, Dr. Jonathan Schapiro, Shlomo Shalev, Doron Turgeman and Dr. Dobroslav Melamed to the Board of Directors of the Company, each for a term expiring at the Company’s next annual general meeting of shareholders.
3. To approve the compensation of Mr. Shlomo Shalev, Chairman of the Board, consisting of a monthly cash payment and options to purchase 1,500,000 ordinary shares of the Company, par value NIS 0.1 each, for an exercise price of NIS 0.60 per share. Such compensation is contingent on Mr. Shalev’s reelection to the Board of Directors.
4. To approve the grant of options to purchase 1,000,000 ordinary shares of the Company, NIS 0.1 par value each, for an exercise price of NIS 0.60 per share to Mr. Josh Levine, the Company’s Chief Executive Officer, as set forth in the notice of the Meeting.
|